Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 2 (2005), Issue 10 (October)

1. Sex and drugs in popular movies: an analysis of the top 200 films.
   J R Soc Med, 98(10): 464-70. [Abstract] [Full-text]
2. Cannabis use and misuse prevalence among people with psychosis.
   Br J Psychiatry, 187: 306-13. [Abstract] [Full-text]
3. Concealment of drugs by police detainees: lessons learned from adverse incidents and from 'routine' clinical practice.
   J Clin Forensic Med, 12(5): 237-41. [Abstract] [Full-text]
4. Impact of substance use on the onset and course of early psychosis.
   Schizophr Res, 79(1): 69-75. [Abstract] [Full-text]
5. What causes the onset of psychosis?
   Schizophr Res, 79(1): 23-34. [Abstract] [Full-text]
6. Risk for schizophrenia--broadening the concepts, pushing back the boundaries.
   Schizophr Res, 79(1): 5-13. [Abstract] [Full-text]
7. Potential of Brassic rapa, Cannabis sativa, Helianthus annuus and Zea mays for phytoextraction of heavy metals from calcareous dredged sediment derived soils.
   Chemosphere, 61(4): 561-72. [Abstract] [Full-text]
8. Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes.
   Plant Cell Physiol, 46(9): 1578-82. [Abstract] [Full-text]
9. Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression.
   Cell Microbiol, 7(11): 1592-602. [Abstract] [Full-text]
10. The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette and cannabis smoking among young people: quasi-experimental pilot study.
    Alcohol Alcohol, 40(6): 535-9. [Abstract] [Full-text]
11. Illicit drug use, alcohol use and problem drinking among infrequent and frequent road ragers.
    Drug Alcohol Depend, 80(2): 169-75. [Abstract] [Full-text]
12. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
    Drug Alcohol Depend, 80(2): 147-59. [Abstract] [Full-text]
13. Paroxysmal atrial fibrillation after recreational marijuana smoking: another "holiday heart"?
    Swiss Med Wkly, 135(27): 412-4. [Abstract] [Full-text]
14. Harm reduction--the cannabis paradox.
    Harm Reduct J, 2: 17. [Abstract] [Full-text]
15. Sex, drugs and chronic illness: health behaviours among chronically ill youth.
    Eur J Public Health, 15(5): 484-8. [Abstract] [Full-text]
16. Comparative study of drug use among undergraduate students at the University of São Paulo--São Paulo campus in 1996 and 2001.
    Rev Bras Psiquiatr, 27(3): 185-93. [Abstract] [Full-text]
17. Parental and Peer Influences on the Risk of Adolescent Drug Use.
    J Prim Prev. [Abstract] [Full-text]
18. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.
    Forensic Sci Int, 155(2): 172-8. [Abstract] [Full-text]
19. Drugs and chronic alcohol abuse in drivers.
    Forensic Sci Int, 155(2): 83-90. [Abstract] [Full-text]
20. Survey of Australians using cannabis for medical purposes.
    Harm Reduct J, 2: 18. [Abstract] [Full-text]
21. Characteristics of relapse to substance use in comorbid adolescents.
    Addict Behav, 30(9): 1811-23. [Abstract] [Full-text]
22. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review.
    Addict Behav, 30(9): 1824-33. [Abstract] [Full-text]
23. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: Results from a double blind, placebo-controlled study.
    Addict Behav, 30(9): 1702-8. [Abstract] [Full-text]
24. What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort.
    Addict Behav, 30(9): 1649-62. [Abstract] [Full-text]
25. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
    Psychopharmacology (Berl), 181(1): 170-8. [Abstract] [Full-text]
26. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
    J Adolesc Health, 37(5): 409. [Abstract] [Full-text]
27. Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada.
    Accid Anal Prev, 37(6): 1025-34. [Abstract] [Full-text]
28. Expected impacts of the Cannabis Infringement Notice scheme in Western Australia on attitudes and drug use of school children.
    Drug Alcohol Rev, 24(4): 337-45. [Abstract] [Full-text]
29. The Cannabis Infringement Notice scheme in Western Australia: A review of policy, police and judicial perspectives.
    Drug Alcohol Rev, 24(4): 331-6. [Abstract] [Full-text]
30. Cannabis law reform in Western Australia: An opportunity to test theories of marginal deterrence and legitimacy *.
    Drug Alcohol Rev, 24(4): 321-30. [Abstract] [Full-text]
31. Expected impacts of the Cannabis Infringement Notice scheme in Western Australia on regular users and their involvement in the cannabis market.
    Drug Alcohol Rev, 24(4): 311-9. [Abstract] [Full-text]
32. Community attitudes towards cannabis law and the proposed Cannabis Infringement Notice scheme in Western Australia.
    Drug Alcohol Rev, 24(4): 301-9. [Abstract] [Full-text]
33. Indirect detection of substituted phenols and cannabis based on the electrochemical adaptation of the Gibbs reaction.
    Anal Bioanal Chem, 383(3): 523-31. [Abstract] [Full-text]
34. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Psychopharmacology (Berl), 182(2): 262-76. [Abstract] [Full-text]
35. Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma.
    Biochem Biophys Res Commun, 337(3): 824-31. [Abstract] [Full-text]
36. Reasoning deficits in ecstasy (MDMA) polydrug users.
    Psychopharmacology (Berl), 181(3): 550-9. [Abstract] [Full-text]
37. Cannabis--psychosis pathway independent of other types of psychopathology.
    Schizophr Res, 79(2): 289-95. [Abstract] [Full-text]
38. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
    Psychopharmacology (Berl), 181(2): 237-43. [Abstract] [Full-text]
39. Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective.
    J Int Neuropsychol Soc, 11(6): 753-65. [Abstract] [Full-text]
40. Mental disorder and violent victimization in a total birth cohort.
    Am J Public Health, 95(11): 2015-21. [Abstract] [Full-text]
41. Limited use of medicinal cannabis but for labeled indications after legalization.
    Pharmacoepidemiol Drug Saf, 14(11): 821-2. [Abstract] [Full-text]
42. Psychobiological correlates of smoking in patients with erectile dysfunction.
    Int J Impot Res, 17(6): 527-34. [Abstract] [Full-text]
43. Substance Use among School-Based Youths in Northern Mexico.
    Am J Addict, 14(5): 464-70. [Abstract] [Full-text]
44. Risk Behaviors for Varying Categories of Disability in NELS:88.
    J Sch Health, 75(9): 350-8. [Abstract] [Full-text]
45. Substance abuse counseling services in secondary schools: a national study of schools and students, 1999-2003.
    J Sch Health, 75(9): 334-41. [Abstract] [Full-text]
46. Substance use, substance choice, and unprotected anal intercourse among young Asian American and Pacific Islander men who have sex with men.
    AIDS Educ Prev, 17(5): 418-29. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.